Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
Posts Tagged ‘NYSE:AZN’
Hedge Funds Have Never Been More Bullish On AstraZeneca plc (AZN)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
10 Best Diabetes Stocks To Buy Now
In this article, we will be taking a look at the 10 best diabetes stocks to buy now.
Is AZN Stock A Buy or Sell?
The Insider Monkey team has completed processing the quarterly 13F filings for the December quarter submitted by the hedge funds and other money managers included in our extensive...
Is AZN A Good Stock To Buy According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
These Hedge Funds Were Wrong About AstraZeneca plc (AZN)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
10 Biggest Pharmaceutical Companies in the World in 2020
In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 (click to skip ahead and see the top 3 pharma...
Hedge Funds Have Never Been This Bullish On AstraZeneca plc (AZN)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Astrazeneca Could Easily Acquire Gilead Sciences
Since June 8, 2020…When Speculation Bubbled About A Possible AstraZeneca-Gilead Sciences Combination [see vertical line in above chart]…The Following “Deal” Metrics Have...
Did Hedge Funds Make The Right Call On AstraZeneca plc (AZN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About AstraZeneca plc (AZN)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Were Hedge Funds Right About AstraZeneca plc (AZN)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Should You Buy AstraZeneca plc (AZN)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
AstraZeneca plc (AZN) vs. Top 20 Hedge Fund Stocks in 2019
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Is AstraZeneca plc (AZN) Going to Burn These Hedge Funds?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Hedge Funds Are Undecided About AstraZeneca plc (AZN)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is AstraZeneca plc (AZN) A Good Stock To Buy?
At Insider Monkey we follow nearly 750 of the best-performing investors and even though many of them lost money in the last couple of months of 2018 (some actually delivered very...
Tesla, General Motors, Alibaba, and More: Why These Stocks Are in the Spotlight
The extended weekend is now over, and Wall Street is once again paying attention to the U.S.
Were Hedge Funds Right About AstraZeneca plc (AZN)?
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Here is What Hedge Funds Think About AstraZeneca plc (AZN)
The market has been volatile as the Federal Reserve continues its rate hikes to normalize the interest rates.
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Hedge Fund and Insider Trading News: Daniel Loeb, Tom Steyer, Ray Dalio, AstraZeneca PLC (AZN), Alteryx Inc (AYX), and More
Daniel Loeb's hedge fund, Third Point, has trimmed the number of nominees it is making to the Campbell Soup board to five, sources tell CNBC.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Opus Point Partners’ AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.
40 Fresh Stories to Know How is it Going in the Financial Markets Today
"U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic data.
7 Over-the-Counter Diet Pills that Work Without Exercise
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S.
AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million in the respiratory biopharmaceutical...
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors.
7 Most Popular Diet Pills That Work Fast Without Exercise
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
AstraZeneca PLC (ADR) (AZN) Rejected Drugs To Be Reconsidered
AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially meant to treat.
China MediTech And AstraZeneca PLC (ADR) (AZN) To Present Savolitinib Phase II Results At The Genitourinary Cancers Symposium 2017
Hutchison China MediTech Limited and AstraZeneca plc (ADR) (NYSE:AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming 2017 Genitourinary...
Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from Clovis Oncology Inc (NASDAQ...
AstraZeneca PLC (ADR) (AZN) Wins A Six Months Paediatric Exclusivity Approval Of Its Symbicort
The US Food and Drug Administration (FDA) has confirmed that Symbicort (budesonide/formoterol) Inhalation Aerosol is worth being granted paediatric exclusivity.
AstraZeneca PLC (ADR) (AZN) Planning Tagrisso Label Expansion To Shore Up Earnings
AstraZeneca plc (ADR) (NYSE:AZN) share price could receive a major boost on the company pursuing a label expansion for its blockbuster Tagrisso.
AstraZeneca plc (ADR) (AZN) CEO Claims The Drug Approval Process Of NHS Is Counterproductive
AstraZeneca plc (ADR) (NYSE:AZN)’s chief executive officer has said that the long negotiation process that the NHS undertakes with drugmakers before approving medications is...
10 Famous Corporate Whistleblowers in Publicly-Traded Companies
It takes a lot of guts for an individual to stand up against huge corporate entities for the overall well-being of the society.
How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)
“By diligently prioritizing, we will continue to successfully launch and commercialize new medicines, meet the needs of our customers and patients, and ultimately help AstraZeneca...
Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment?
Tagrisso, a lung cancer med from AstraZeneca plc (ADR) (NYSE:AZN) is already in early approval based on mid-stage studies, which demonstrates the possibility of it replacing the...
AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division
AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation.
AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY) on a long-lasting class...
AstraZeneca PLC (ADR) (AZN) Retreats On Some Durvalumab Plans
AstraZeneca PLC (ADR) (NYSE:AZN) will no longer seek early regulatory review of its drug candidate durvalumab in patients with head and neck cancers.
AstraZeneca PLC (ADR) (AZN) Unveils Positive SOLO-2 Data
AstraZeneca plc (ADR) (NYSE:AZN) has recently released encouraging data from SOLO-2, a phase 3 clinical trial evaluating the efficacy of Lynparza (olaparib) as a monotherapy for...
AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas
AstraZeneca Plc (ADR) (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization agreement with a subsidiary...
Delta Air Lines Inc. (DAL), Summit Therapeutics PLC (ADR) (SMMT) & More: A Look at Five Stocks on the Move Today
Markets have opened at shaky note with major indices treading on margin.
Why Allergan, eBay, Dynavax, KBR, and More Are Trending
It's a red day on Wall Street, as all three major indexes are off by around 0.35%, potentially due to some market participants remaining on the sidelines until the Deutsche Bank...
